Top compounds associated with response to HLA-G


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.077 0.04
mRNA CUDC-101 GDSC1000 pan-cancer AAC -0.07 0.04
mRNA ML083 CTRPv2 pan-cancer AAC 0.078 0.04
mRNA CIL41 CTRPv2 pan-cancer AAC -0.1 0.04
mRNA Topotecan CCLE pan-cancer AAC -0.088 0.04
mRNA Axitinib FIMM pan-cancer AAC -0.34 0.04
mRNA BRD-K49290616 CTRPv2 pan-cancer AAC 0.15 0.04
mRNA erastin CTRPv2 pan-cancer AAC -0.069 0.04
mRNA LY-2183240 CTRPv2 pan-cancer AAC -0.062 0.05
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.068 0.05
Download CSV